Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page
Your Search Results: 29 Clinics in the Bellin Health health system


The results below represent 22,424 women who should have had one or more cervical cancer screening tests during the previous 36 months or one cervical cancer screening test and a human papillomavirus test within the last 5 years. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
ALGOMA NURSING HOME PROGRAM

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH CRIVITZ

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH DAGGETT

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC ALGOMA
N=412
71.84 %
View Historical Data
BELLIN HEALTH FMC ASHWAUBENON
N=4339
82.39 %
View Historical Data
BELLIN HEALTH FMC ASHWAUBENON IM AND PEDIATRICS
N=1119
87.31 %
View Historical Data
BELLIN HEALTH FMC BELLEVUE
N=2576
86.30 %
View Historical Data
BELLIN HEALTH FMC BONDUEL

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC BRILLION
N=597
73.03 %
View Historical Data
BELLIN HEALTH FMC DE PERE EAST
N=1496
82.89 %
View Historical Data
BELLIN HEALTH FMC DE PERE WEST
N=1548
87.40 %
View Historical Data
BELLIN HEALTH FMC DENMARK

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC ESCANABA
N=1005
80.10 %
View Historical Data
BELLIN HEALTH FMC HOWARD
N=2368
82.31 %
View Historical Data
BELLIN HEALTH FMC IRON MOUNTAIN
N=1947
64.20 %
View Historical Data
BELLIN HEALTH FMC KEWAUNEE
N=518
78.96 %
View Historical Data
BELLIN HEALTH FMC LUXEMBURG

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC MANITOWOC

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC OCONTO
N=361
74.79 %
View Historical Data
BELLIN HEALTH FMC OCONTO FALLS
N=613
70.31 %
View Historical Data
BELLIN HEALTH FMC PULASKI
N=248
64.11 %
View Historical Data
BELLIN HEALTH FMC SEYMOUR

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC SURING

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC WEBSTER AVE AND CLINICA HISPANA
N=942
74.73 %
View Historical Data
BELLIN HEALTH FMC WRIGHTSTOWN

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH MARINETTE
N=2335
76.79 %
BELLIN HEALTH MENOMINEE

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH PESHTIGO

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH STURGEON BAY

The number of patients or providers is too small for
purposes of reliably reporting performance

There is good evidence that cervical cancer screening significantly reduces the incidence of and mortality from cervical cancer. The US Preventive Services Task Force suggests most of the benefit can be obtained by beginning screening at age 21. Recommendations include screening for women ages 21 through 64 with cytology (Pap smear) at least every 3 years and for women ages 30 through 64 who want to lengthen the screening interval, screening with a combination of cytology and human papillomavirus (HPV) testing every 5 years. An individuals specific clinical considerations, risk factors, etc. determine if testing is needed at a more frequent interval. It is recommended that women speak with their health care providers to determine the appropriate interval for their particular situation. There is limited evidence to determine the benefits of continued screening in women older than 65, due to declining incidence of high-grade cervical lesions after middle age. There is fair evidence that screening women older than 65 is associated with an increased risk for potential harm (US Preventive Services Task Force). Therefore, it is also recommended that women over age 65 speak with their health care providers to determine if continued screening is appropriate for their personal medical condition.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.